Risk factors for type 1 reactions in leprosy
Affiliations
- PMID: 9465153
Item in Clipboard
Risk factors for type 1 reactions in leprosy
Int J Lepr Other Mycobact Dis.
1997 Dec.
Abstract
A cohort of new borderline leprosy patients seen over a 7-year period were examined retrospectively for risk of type 1 reactions (T1R) associated with 12 clinical and laboratory parameters. Logistic regression analysis was used to identify a strong link between facial patches and cutaneous T1R and enlarged ulnar nerves and neural T1R. Anti-phenolic glycolipid-I seropositivity, a positive bacterial index, and disease in more than two body areas were also identified as risk factors for T1R. These data indicate that there are important clinical data which can be used to predict an individual patient's risk of developing T1R.
Similar articles
-
Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.Clin Infect Dis. 2007 Jan 1;44(1):33-40. doi: 10.1086/509923. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143812
-
IgM anti-phenolic glycolipid-I antibody measurements from skin-smear sites: correlation with venous antibody levels and the bacterial index.Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):465-8. Int J Lepr Other Mycobact Dis. 1997. PMID: 9465156
-
Contribution of type 1 reactions to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone.Int J Lepr Other Mycobact Dis. 1998 Sep;66(3):340-7. Int J Lepr Other Mycobact Dis. 1998. PMID: 9934360
-
Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.Am J Trop Med Hyg. 2006 May;74(5):868-79. Am J Trop Med Hyg. 2006. PMID: 16687695
-
Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions.Lepr Rev. 2004 Dec;75(4):310-26. Lepr Rev. 2004. PMID: 15682969 Review.
Cited by
-
Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study.Sci Rep. 2019 Nov 29;9(1):17931. doi: 10.1038/s41598-019-54213-y. Sci Rep. 2019. PMID: 31784594 Free PMC article.
-
Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.An Bras Dermatol. 2013 Sep-Oct;88(5):787-92. doi: 10.1590/abd1806-4841.20132004. An Bras Dermatol. 2013. PMID: 24173185 Free PMC article. Review.
-
Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.Mem Inst Oswaldo Cruz. 2015 Nov;110(7):914-20. doi: 10.1590/0074-02760150198. Mem Inst Oswaldo Cruz. 2015. PMID: 26560982 Free PMC article.
-
High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.Clin Exp Immunol. 2002 May;128(2):333-8. doi: 10.1046/j.1365-2249.2002.01791.x. Clin Exp Immunol. 2002. PMID: 11985524 Free PMC article.
-
Leprosy patients with deformities at post-elimination stage: The Bangladesh experience.Skin Health Dis. 2020 Oct 14;1(1):e5. doi: 10.1002/ski2.5. eCollection 2021 Mar. Skin Health Dis. 2020. PMID: 35664820 Free PMC article.